Maiia Pro
Store data observed · From public App Store data · How we score apps
- Medical
- App Store
- United States
- —0 ratings
- Free download
- Updated
- Observed
Ratings
Observed0
Chart position
Observed—Not on the top charts
90-day growth
—not enough history yet
Opportunity score
AI-derived0/100Weak · low confidence
Own Maiia Pro? Share your real numbers
Your numbers stay private. They only tune MRRBeam's estimates, so every app's figures get more accurate.
Sign in to share them.
Made Maiia Pro? Add a “Tracked in Medical” badge to your site
About Maiia ProObserved
Maiia Pro is a Medical app by Docavenue on the United States App Store. Released Feb 29, 2020; last updated Oct 7, 2026 (version 4.5.0). Maiia Pro is free to download.
MRRBeam rates the success of Maiia Pro 0/100 (early stage).
Maiia est une suite de service, co-construite avec le corps médical. Grâce à son offre d'agenda et de téléconsultation, elle aide des milliers de professionnels de santé à se concentrer sur le soin de leurs patients.
- Success score
- 0/100 Early stage
- In Medical
- Outside the top 100
- Chart position
- Not on the top charts
- Developer
- Docavenue
Loading the full report…
Maiia Pro: common questions
- What is Maiia Pro?
- Maiia Pro is a Medical app developed by Docavenue, available on the App Store. It was first released on Feb 29, 2020.
- How much does Maiia Pro cost?
- Maiia Pro is free to download.
- Is Maiia Pro successful?
- MRRBeam rates the success of Maiia Pro 0/100 (early stage). The success score combines rating volume, chart position and average rating.
- When was Maiia Pro last updated?
- Maiia Pro was last updated on Oct 7, 2026 (version 4.5.0).
- What are alternatives to Maiia Pro?
- Similar Medical apps tracked by MRRBeam include CVS Health, MyChart, healow, UnitedHealthcare and GoodRx: Prescription Savings.
- Is there room to build a competitor to Maiia Pro?
- MRRBeam's opportunity score for Maiia Pro is 0/100. Limited opening: an older app, little observable demand and a crowded category with entrenched leaders.